(Q44432065)

2 December 2017

title

Gene modulation by the cyclooxygenase inhibitor, sulindac sulfide, in human colorectal carcinoma cells: possible link to apoptosis (English)

1 reference

2 December 2017

1 reference

Frank G Bottone

1

1 reference

2 December 2017

Jeanelle M Martinez

2

1 reference

2 December 2017

Jennifer B Collins

3

1 reference

2 December 2017

Cynthia A Afshari

4

1 reference

2 December 2017

Thomas E Eling

5

1 reference

2 December 2017

language of work or name

English

0 references

publication date

6 May 2003

1 reference

Journal of Biological Chemistry

2 December 2017

number of pages

12

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

2 December 2017

volume

278

1 reference

2 December 2017

issue

28

1 reference

2 December 2017

page(s)

25790-25801

1 reference

Chemoprevention of colorectal cancer

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301002200

Cyclooxygenase-2--10 years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301002200

Selective cyclooxygenase-2 inhibitors show a differential ability to inhibit proliferation and induce apoptosis of colon adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301002200

Growth inhibition and induction of apoptosis in colorectal tumor cells by cyclooxygenase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301002200

Inhibition of NF-kappaB and AP-1 activation by R- and S-flurbiprofen

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301002200

Progression and NSAID-induced apoptosis in malignant melanomas are independent of cyclooxygenase II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301002200

Malignant transformation and antineoplastic actions of nonsteroidal antiinflammatory drugs (NSAIDs) on cyclooxygenase-null embryo fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301002200

Peroxisome proliferator-activated receptor-gamma is a target of nonsteroidal anti-inflammatory drugs mediating cyclooxygenase-independent inhibition of lung cancer cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301002200

Sulindac sulfide, but not sulindac sulfone, inhibits colorectal cancer growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301002200

Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301002200

Apoptosis induced by sulindac sulfide in epithelial and mesenchymal cells from human abdominal neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301002200

Autophagy delays sulindac sulfide-induced apoptosis in the human intestinal colon cancer cell line HT-29.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301002200

The NSAID sulindac reverses rectal adenomas in colectomized patients with familial adenomatous polyposis: clinical results of a dose-finding study on rectal sulindac administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301002200

Molecular cloning and characterization of human nonsteroidal anti-inflammatory drug-activated gene promoter. Basal transcription is mediated by Sp1 and Sp3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301002200

Genomics and array technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301002200

MAPS: a microarray project system for gene expression experiment information and data validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301002200

Validation of array-based gene expression profiles by real-time (kinetic) RT-PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301002200

Dual function of nonsteroidal anti-inflammatory drugs (NSAIDs): inhibition of cyclooxygenase and induction of NSAID-activated gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301002200

Expression and regulation of nonsteroidal anti-inflammatory drug-activated gene (NAG-1) in human and mouse tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301002200

Validation of a model of colon cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301002200

The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: evidence of different mechanisms of action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301002200

Expression profile analysis of colon cancer cells in response to sulindac or aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301002200

Growth-suppressive effect of non-steroidal anti-inflammatory drugs on 11 colon-cancer cell lines and fluorescence differential display of genes whose expression is influenced by sulindac

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301002200

Indomethacin induces differential expression of beta-catenin, gamma-catenin and T-cell factor target genes in human colorectal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301002200

Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301002200

EGR1 target genes in prostate carcinoma cells identified by microarray analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301002200

DNA microarrays identification of primary and secondary target genes regulated by p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301002200

Detection of differentially expressed genes in human colon carcinoma cells treated with a selective COX-2 inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301002200

Apo2L/TRAIL differentially modulates the apoptotic effects of sulindac and a COX-2 selective non-steroidal anti-inflammatory agent in Bax-deficient cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301002200

Complexes containing activating transcription factor (ATF)/cAMP-responsive-element-binding protein (CREB) interact with the CCAAT/enhancer-binding protein (C/EBP)-ATF composite site to regulate Gadd153 expression during the stress response

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301002200

Involvement of transcriptional repressor ATF3 in acceleration of caspase protease activation during DNA damaging agent-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301002200

ATF3 induction following DNA damage is regulated by distinct signaling pathways and over-expression of ATF3 protein suppresses cells growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301002200

NF-kappaB mediates FGF signal regulation of msx-1 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301002200

Chromosome missegregation and apoptosis in mice lacking the mitotic checkpoint protein Mad2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301002200

Using cyclooxygenase-2 inhibitors as molecular platforms to develop a new class of apoptosis-inducing agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301002200

COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301002200

Cyclooxygenase-2 inhibitors in tumorigenesis (part I)

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301002200

Cyclooxygenase-2 inhibitors in tumorigenesis (Part II)

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301002200

Chemoprevention of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301002200

Purification, characterization and selective inhibition of human prostaglandin G/H synthase 1 and 2 expressed in the baculovirus system

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301002200

Morphological Diversity of the Avian Foot Is Related with the Pattern ofmsxGene Expression in the Developing Autopod

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M301002200

21 January 2018

Identifiers

DOI

10.1074/JBC.M301002200

1 reference

2 December 2017

1 reference